Adage Capital Partners Gp, L.L.C. Edwards Lifesciences Corp Transaction History

Adage Capital Partners Gp, L.L.C.

$54.6 Billion
Q3 2024

A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 834,752 shares of EW stock, worth $61.5 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

834,752

Previous 649,663 28.49%

Holding current value

$61.5 Million

Previous $60 Million 8.21%

% of portfolio

0.1%

Previous 0.11%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$59.7 - $93.78 $11 Million - $17.4 Million	185,089 Added 28.49%	834,752 $55.1 Million
Q2 2024 Aug 14, 2024	SELL	$84.3 - $94.31 $54.3 Million - $60.8 Million	-644,300 Reduced 49.79%	649,663 $60 Million
Q1 2024 May 15, 2024	BUY	$72.54 - $95.56 $60.6 Million - $79.8 Million	834,818 Added 181.82%	1,293,963 $124 Million
Q4 2023 Feb 14, 2024	BUY	$61.71 - $77.76 $28.3 Million - $35.7 Million	459,145 New	459,145 $35 Million
Q2 2023 Aug 14, 2023	SELL	$81.41 - $94.33 $9.26 Million - $10.7 Million	-113,803 Reduced 21.49%	415,805 $39.2 Million
Q1 2023 May 15, 2023	BUY	$74.26 - $84.51 $10.1 Million - $11.5 Million	135,742 Added 34.46%	529,608 $43.8 Million
Q4 2022 Feb 14, 2023	SELL	$68.3 - $87.44 $7.36 Million - $9.42 Million	-107,700 Reduced 21.47%	393,866 $29.4 Million
Q3 2022 Nov 14, 2022	SELL	$82.37 - $107.29 $7.91 Million - $10.3 Million	-96,000 Reduced 16.07%	501,566 $41.4 Million
Q2 2022 Aug 15, 2022	SELL	$86.5 - $128.27 $4.71 Million - $6.98 Million	-54,400 Reduced 8.34%	597,566 $56.8 Million
Q1 2022 May 16, 2022	SELL	$101.96 - $128.34 $1.36 Million - $1.71 Million	-13,300 Reduced 2.0%	651,966 $76.7 Million
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $457,391 - $561,924	-4,300 Reduced 0.64%	665,266 $86.2 Million
Q3 2021 Nov 15, 2021	SELL	$102.91 - $122.75 $638,042 - $761,050	-6,200 Reduced 0.92%	669,566 $75.8 Million
Q2 2021 Aug 16, 2021	SELL	$83.84 - $104.76 $1.69 Million - $2.12 Million	-20,200 Reduced 2.9%	675,766 $70 Million
Q1 2021 May 17, 2021	BUY	$78.68 - $90.67 $314,720 - $362,680	4,000 Added 0.58%	695,966 $58.2 Million
Q4 2020 Feb 16, 2021	SELL	$71.69 - $91.23 $336,943 - $428,781	-4,700 Reduced 0.67%	691,966 $63.1 Million
Q3 2020 Nov 16, 2020	SELL	$67.19 - $87.44 $1.23 Million - $1.6 Million	-18,285 Reduced 2.56%	696,666 $55.6 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $22.3 Million - $29.8 Million	387,384 Added 118.26%	714,951 $49.4 Million
Q1 2020 May 15, 2020	BUY	$52.41 - $81.0 $8.08 Million - $12.5 Million	154,126 Added 88.86%	327,567 $61.8 Million
Q4 2019 Feb 14, 2020	SELL	$71.7 - $82.09 $3.9 Million - $4.47 Million	-54,400 Reduced 23.88%	173,441 $40.5 Million
Q3 2019 Nov 14, 2019	SELL	$61.55 - $75.43 $1.52 Million - $1.87 Million	-24,769 Reduced 9.81%	227,841 $50.1 Million
Q2 2019 Aug 14, 2019	SELL	$55.74 - $64.41 $6.6 Million - $7.63 Million	-118,440 Reduced 31.92%	252,610 $46.7 Million
Q1 2019 May 15, 2019	BUY	$47.89 - $64.05 $7.99 Million - $10.7 Million	166,882 Added 81.74%	371,050 $71 Million
Q4 2018 Feb 14, 2019	SELL	$46.41 - $56.94 $1.29 Million - $1.58 Million	-27,692 Reduced 11.94%	204,168 $31.3 Million
Q3 2018 Nov 14, 2018	SELL	$45.7 - $58.03 $12.5 Million - $15.9 Million	-273,500 Reduced 54.12%	231,860 $40.4 Million
Q2 2018 Aug 14, 2018	SELL	$42.45 - $51.3 $9.75 Million - $11.8 Million	-229,775 Reduced 31.26%	505,360 $73.6 Million
Q1 2018 May 15, 2018	BUY	$37.19 - $47.45 $6.97 Million - $8.89 Million	187,343 Added 34.2%	735,135 $103 Million
Q4 2017 Feb 14, 2018	BUY	$33.79 - $39.39 $10.9 Million - $12.7 Million	321,750 Added 142.34%	547,792 $61.7 Million
Q3 2017 Nov 14, 2017	BUY	$36.29 - $38.83 $8.2 Million - $8.78 Million	226,042	226,042 $24.7 Million

Others Institutions Holding EW

# of Institutions

1,347

Shares Held

458M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $45.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.

Account

Adage Capital Partners Gp, L.L.C. Edwards Lifesciences Corp Transaction History